Centro de Química Estrutural, Instituto Superior Técnico, Universidade Técnica de Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal.
J Inorg Biochem. 2012 Sep;114:38-46. doi: 10.1016/j.jinorgbio.2012.04.019. Epub 2012 May 4.
The O,S-donor analogues of maltol and deferiprone (DMHP), respectively, thiomaltol and DMHTP, have been investigated in solution for their iron-complexation ability, as well as their electrochemical behaviors, in the presence and absence of iron, aimed at the rationalization of their anti-oxidant activity, particularly, as hydroxyl radical scavengers and inhibitors of lipid peroxidation. The results were compared with those of the O,O-donor compounds and revealed that all the compounds are good iron chelators (pFe=14.1-20.2), but the O,S-donor ligands being somewhat weaker than the corresponding oxo-analogues. Also all the ligands appear to be able to prevent the redox cycling of iron, a relevant anti-oxidant activity, which seems to be primary due to their high capacity to form iron complexes which are not effective in promoting free radical reactions. This is a significant feature for the development of leading analogues as drug candidates with co-adjuvant roles in oxidative-stress dependent pathologies.
甲硫醇和去铁酮(DMHP)的 O,S-供体类似物,分别为硫代甲硫醇和 DMHTP,已在溶液中进行了研究,以研究其与铁的络合能力以及它们在有铁和无铁存在下的电化学行为,旨在合理化它们的抗氧化活性,特别是作为羟基自由基清除剂和脂质过氧化抑制剂。结果与 O,O-供体化合物的结果进行了比较,结果表明所有化合物都是良好的铁螯合剂(pFe=14.1-20.2),但 O,S-供体配体的强度略低于相应的氧类似物。此外,所有配体似乎都能够防止铁的氧化还原循环,这是一种相关的抗氧化活性,这主要似乎是由于它们能够形成不易有效促进自由基反应的铁络合物。这是开发作为在依赖氧化应激的病理学中具有辅助作用的候选药物的先导类似物的重要特征。